The landscape of candidemia during the COVID-19 pandemic.
Emma E SeagleBrendan R JacksonShawn R LockhartOurania GeorgacopoulosNatalie S NunnallyJeremy RolandDevra M BarterHelen L JohnstonChristopher A CzajaHazal KayaliogluPaula ClogherAndrew RevisMonica M FarleyLee H HarrisonSarah Shrum DavisErin C PhippsBrenda L TesiniWilliam SchaffnerTiffanie M MarkusMeghan M LymanPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
One quarter of candidemia patients had COVID-19. These patients were less likely to have certain underlying conditions and recent surgery commonly associated with candidemia and more likely to have acute risk factors linked to COVID-19 care, including immunosuppressive medications. Given the high mortality, it is important for clinicians to remain vigilant and take proactive measures to prevent candidemia in patients with COVID-19.